Creative Medical filed two patent applications regarding use of immune system cells to stimulate blood vessel formation for the treatment of lower back pain, and to support intradiscal stem cell administration to treat degenerative disc disease.
Medicrea raised €13.0MM (~US $14.5MM) in a private placement. Funds will support development of the UNiD™ Adaptive Spine Intelligence platform and commercialization of a new range of 3D-printed titanium interbody cages.